Baseline characteristics for all patients enrolled on study
| Characteristics . | Median . | Range . |
|---|---|---|
| Age (years) | 61 | 47-75 |
| Gender (M/F) | 19/12 | N/A |
| Serum IgM (mg/dL) | 3375 | 345-7430 |
| Serum IgA (mg/dL) | 47 | 18-725 |
| Serum IgG (mg/dL) | 715 | 222-3890 |
| Hemoglobin (g/dL) | 10.7 | 8.3-13.3 |
| Hematocrit (%) | 32.3 | 24.1-38.0 |
| Platelet (mm3) | 255 000 | 68 000-584 000 |
| B2-microglobulin (mg/L) | 3.6 | 1.9-7.2 |
| ISSWM score | 2 | 0-3 |
| Adenopathy | 18 (58.1%) | N/A |
| Splenomegaly | 2 (6.5%) | N/A |
| Bone marrow involvement (%) | 60 | 10-95 |
| Characteristics . | Median . | Range . |
|---|---|---|
| Age (years) | 61 | 47-75 |
| Gender (M/F) | 19/12 | N/A |
| Serum IgM (mg/dL) | 3375 | 345-7430 |
| Serum IgA (mg/dL) | 47 | 18-725 |
| Serum IgG (mg/dL) | 715 | 222-3890 |
| Hemoglobin (g/dL) | 10.7 | 8.3-13.3 |
| Hematocrit (%) | 32.3 | 24.1-38.0 |
| Platelet (mm3) | 255 000 | 68 000-584 000 |
| B2-microglobulin (mg/L) | 3.6 | 1.9-7.2 |
| ISSWM score | 2 | 0-3 |
| Adenopathy | 18 (58.1%) | N/A |
| Splenomegaly | 2 (6.5%) | N/A |
| Bone marrow involvement (%) | 60 | 10-95 |
N/A, not applicable.